Development of a biochip for analyzing polymorphism of the biotransformation genes

Molecular Biology

Volumn 39, Issue 3, 2005, Pages 357-365

  Glotov, A S ^a,b   Nasedkina, T V ^a   Ivaschenko, T E ^b   Urasov, R A ^a   Surzhikov, S A ^a   Pan'kov, S V ^a   Chudinov, A V ^a   Baranov, V S ^b   Zasedatelev, A S ^a  

^a ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

^b D O OTT RESEARCH INSTITUTE OF OBSTETRICS   (Russian Federation)

Author keywords

Diagnosis; Genetic predisposition; Multiplex PCR; Oligonucleotide biochips; Pharmacogenetics; Polymorphism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ARYLAMINE ACETYLTRANSFERASE; CYTOCHROME P450 1A1; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; DNA; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; OLIGONUCLEOTIDE; UNCLASSIFIED DRUG;

ARTICLE; BIOTRANSFORMATION; CONTROLLED STUDY; DNA MICROARRAY; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; HYBRIDIZATION; PHARMACOGENETICS;

EID: 21544457748     PISSN: 00268933     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11008-005-0050-8     Document Type: Article

References (23)

1. Baranov V.S., Baranova E.V., Ivashchenko T.E., Aseev M.V., 2000. Genom cheloveka i geny "predraspolozhennosti" (Vvedenie v prediktivnuyu meditsinu) (Human Genome and Predisposition Genes: Introduction to Predictive Medicine), St. Petersburg: Intermedika.
2. Opredelenie geneticheskoi predraspolozhennosti k nasledstvennym i mul'tifaktorial'nym zabolevaniyam. Geneticheskii pasport. Metodicheskie rekomendatsii (Determination of Genetic Predisposition to Hereditary and Multifactor Diseases. Genetic Passport. Methodological Guidelines), St Petersburg: Foliant, 2001.
3. Ivashchenko, T.E., Strekalov D.L., Solov'eva D.V., Aseev M.V., Baranov V.S., Khavinson V.Kh. 2004. Testing for Genetic Predisposition to Multifactor Diseases and the Genetic Passport. In: Molekulyarno-biologicheskie tekhnologii v meditsinskoi praktike (Molecular-Biological Technologies in Practical Medicine), Novosibirsk: Al'ta Vista, pp. 9-28.
4. Baranov V.S., Baranova E.V., Ivashchenko T.E., 2003. A scientific basis of predictive medicine. In: Molekulyarno-biologicheskie tekhnologii v meditsinskoi praktike (Molecular-Biological Technologies in Practical Medicine), Novosibirsk: Al'ta Vista, pp. 3-19.
5. Lyakhovich V.V., Vavilin V.A., 2003. Pharmacogenetics today. In: Molekulyarno-biologicheskie tekhnologii v meditsinskoi praktike (Molecular-Biological Technologies in Practical Medicine), Novosibirsk: Al'ta Vista, pp. 20-27.
6. Meyer J.M., Ginsburg G.S. 2002. The path to personalized medicine. Curr. Opin. Chem. Biol. 6, 434-438.
7. Basile V.S., Masellis M., Potkin S.G., Kennedy J.L. 2002. Pharmacogenomics in schizophrenia: The quest for individualized therapy. Hum. Mol. Genet. 11, 2517-2530.
8. Kirchheiner J., Brosen K., Dahl M.L., Gram L.F., Kasper S., Roots I., Sjoqvist F., Spina E., Brockmoller J. 2001. CYP2D6 and CYP2C19 genotype-based dose recommendations for antidepressants: A first step towards subpopulation-specific dosages. Acta. Psychiatr. Scand. 104, 173-192.
9. Sachse C., Brockmoller J., Bauer S., Roots I. 1997. Cytochrome P450 2D6 variants in a Caucasian population: Allele frequencies and phenotypic consequences. Am. J. Hum. Genet. 60, 284-295.
10. Krajinovic M., Labuda D., Mathonnet G., Labuda M., Moghrabi A., Champagne J., Sinnett D. 2002. Polymorphisms in genes encoding drugs and xenobiotic metabolizing enzymes, DNA repair enzymes, and response to treatment of childhood acute lymphoblastic leukemia. Clin. Cancer. Res. 8, 802-810.
11. Scordo M.G., Aklillu E., Yasar U., Dahl M.L., Spina E., Ingelman-Sundberg M. 2001. Genetic polymorphism of cytochrome P450 2C9 in a Caucasian and a black African population. Br. J. Clin. Pharmacol. 52, 447-450.
12. Kovalenko, S.P., 2003. Individualized selection of medicinal preparations for treating oncological diseases. In: Molekulyarno-biologicheskie tekhnologii v meditsinskoi praktike (Molecular-Biological Technologies in Practical Medicine), Novosibirsk: Al'ta Vista, pp. 158-165.
13. Kolchinsky A., Mirzabekov A. 2002. Analysis of SNPs and other genomic variations using gel-based chips. Hum. Mutat. 19 (4), 343-360.
14. Kolchinsky A.M., Gryadunov D.A., Lysov Yu.P., Mikhailovich V.M., Nasedkina T.V., Turygin A.Yu., Rubina A.Yu., Barsky V.E., Zasedatelev A.S. 2004. Gel-based microchips: History and prospects, Mol. Biol., 38, 5-16.
15. http://www1.amershambiosciences.com/APTRIX/upp 01077.nsf/Content/ Products?OpenDocument&parentid= 568694&moduleid=165695#content
16. Landi S., Gemignani E, Gioia-Patricola L., Chabrier A., Canzian F. 2003. "MetaboChip." Biotechniques. 35, 816-820, 822, 824-827.
17. Wen S.Y., Wang H., Sun O.J., Wang S.Q. 2003. Rapid detection of the known SNPs of CYP2C9 using oligonucleotide microarray. World J. Gastroenterol. 9, 1342-1346.
18. Labuda D., Krajinovic M., Richer C., Skoll A., Sinnett H., Yotova V., Sinnett D. 1999. Rapid detection of CYP1A1, CYP2D6, and NAT variants by multiplex polymerase chain reaction and allele-specific oligonucleotide assay. Anal. Biochem. 275 (1), 84-92.
19. http://www.jurilab.com/default.asp?toc=9#p1
20. Maniatis, T., Fritsch, E.F., Sambrook, J. 1982. Molecular cloning: A laboratory manual. Cold Spring Harbor, N.Y: Cold Spring Harbor Lab. Press.
21. Fotin, A., Drobyshev A., Proudnikov D., Perov A., Mirzabekov A. 1998. Parallel thermodynamic analysis of duplexes on oligodeoxyribonucleotide microchips. Nucleic Acids Res. 26, 1515-1521.
22. Sachse C., Brockmoller J., Bauer S., Roots I. 1997. Cytochrome P450 2D6 variants in a Caucasian population: Allele frequencies and phenotypic consequences. Am. J. Hum. Genet. 60, 284-295.
23. http://molbiol.ru/cgi/yandmarkup@HndlQuery =1578909920&PageNum= 0&g=0&d=0